vivoFlow

As in humans, the Angiotensin I Converting Enzyme 2 (ACE2) receptors of hamsters naturally permit binding of the SARS-CoV-2 virus spike protein. This suggests that hamsters are an important model [...]

Smoking has reached an epidemic proportion worldwide and its effect in terms of health-related issues is huge. While smoking prevention and cessation are key to bringing an end to this epidemic, [...]

Longitudinal studies offer a wealth of information, particularly for diseases progression or development studies. In addition, smaller sample sizes are possible to accumulate significant data, as [...]

SCIREQ is preparing for the upcoming Experimental Biology Meeting that will take place in Orlando from April 6-9, 2019. At this meeting we launch our latest development: the vivoFlow – WBP (Whole [...]

emka & SCIREQ offer a unique perspective into the preclinical study of heart and lung diseases, allowing for novel insights into cardiopulmonary diseases such as heart failure, arrhythmia, [...]

Oxygen deficiency or hypoxia can contribute to the development or exacerbation of many disorders including strokes or chronic lung diseases. The first defense against hypoxia is the hypoxic [...]

The emka & SCIREQ team will be attending the Experimental Biology 2017 conference in Chicago! We will present and demonstrate our wide range of preclinical instruments for neuro, pulmonary [...]

Conscious measurements allow researchers to quantify effects of diseases or therapeutic interventions on the drive to breathe, also referred to as “Pumping apparatus” 1. The breathing drive [...]

The emka & SCIREQ team will be attending the Society for Neuroscience 2016 conference in San Diego! We will present and demonstrate our wide range of preclinical instruments for neuro, [...]

Our team of Application Specialist are traveling to sunny San Diego next week to attend the Experimental Biology conference yet again! We will present and demonstrate our solutions for [...]